Background

The Drug Enforcement Administration is accepting comments through Oct. 4 on a proposal to add the central nervous stimulant methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine), including its salts, isomers, and salts of isomers, to schedule I of the Controlled Substances Act. This rule would impose the administrative, civil, and criminal sanctions and regulatory controls applicable to schedule I substances on the importation, exportation, manufacture, distribution, possession, research, conduct of instructional activities, and chemical analysis of this substance.

Copyright © 2022 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 

Close

Cookie Consent

We have updated our Privacy Policy relating to our use of cookies on our website and the sharing of information. By continuing to use our website or subscribe to our publications, you agree to the Privacy Policy and Terms & Conditions.